Abeona Therapeutics logo
Abeona Therapeutics ABEO
€ 5.86 -3.0%

Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024

report update icon

Abeona Therapeutics Kennzahlen 2011-2024 | ABEO

Kennzahlen Jährlich Abeona Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-2.8 -0.6 -0.0 -2.1 -1.6 -5.5 -23.3 -7.2 -5.0 -0.2 2.0 -1.1 -10.7

P/S

42.7 15.5 0.3 17.7 - 104.5 761.1 176.9 69.3 6.6 4.5 2.6 14.6

EPS

-2.5 -5.5 -21.6 -0.9 -1.5 -1.2 -0.7 -0.6 -0.5 -15.3 3.1 -0.5 -0.2

EV (Enterprise Value)

184 M 45.2 M 5.3 M 213 M 35 M 335 M 508 M 100 M 44.2 M 6.35 M 24.1 M 29.8 M 45.9 M

EBITDA per Share

-2.1 -6.08 -22 -0.474 -1.38 -1.17 -0.651 -0.675 -0.652 -1.61 -7.53 -8.06 -19.1

EV/EBITDA

0.1 -3.8 0.1 -5.8 -18.4 -3.8 -2.0 0.3 -2.3 -2.8 -3.6

PEG

-0.0 -0.0 -0.0 -0.05 0.06 0.07 7.46 0.35 -0.05 0.0 0.02 0.01 -0.17

P/B

10.1 0.8 0.0 1.7 0.7 2.3 3.7 1.6 1.1 1.3 -0.6 -0.7 -1.5

P/CF

-4.0 -0.5 -0.0 -4.9 -1.7 -5.3 -26.8 -11.6 -6.7 -3.8 -9087.5 -2.9 -3.5

ROE %

-365.49 -148.34 -200.47 -82.14 -42.75 -42.28 -16.06 -22.07 -21.45 -556.02 -30.10 61.68 14.38

ROA %

-84.67 -61.82 -106.72 -55.71 -34.15 -32.50 -15.28 -19.70 -18.15 -161.49 725.77 -608.79 -66.90

ROCE %

-317.92 -190.26 -212.04 -44.40 -41.74 -37.76 -16.08 -23.24 -23.60 -22.88 45.57 88.10 93.71

Current Ratio

1.3 1.7 2.1 2.3 3.4 4.4 25.1 8.4 27.5 4.0 0.1 0.3 0.3

DSO

- 387.2 182.5 - - 9.9 46.7 50.9 40.4 13.8 13.2 69.6 65.8

DIO

- - - - - - - - - - - 265.2 45.3

DPO

- - - - - - - - - - 2520.0 2787.4 514.2

Betriebszyklus

- 387.2 182.5 - - - - - - - 13.2 334.8 111.1

Finanzkreislauf

- 387.2 182.5 - - - - - - - -2506.7 -2452.6 -403.1

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Abeona Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.63 0.19 -1.16 - -0.48 -0.92 -0.54 - -1 1.36 -3.8 - -1.8 -3.93 -0.17 - -0.08 -0.14 -0.52 -0.3 -0.35 -0.49 -0.39 -0.36 -0.34 -0.26 -0.22 -0.19 -0.13 -0.21 -0.13 - -0.08 -0.2 -0.17 - -0.19 -0.16 -0.1 - -4.15 -0.51 -0.03 - -1.77 0.03 0.14 - -0.63 -0.46 -0.22 - - -0.09 -0.12

EBITDA per Share

-0.31 -0.43 -0.51 - -0.44 -0.55 -0.67 - -1.34 -1.24 -3.41 - -3.17 -3.12 -0.15 - -0.06 -0.13 -0.5 -0.3 -0.31 -0.45 -0.36 -0.38 -0.34 -0.26 -0.22 -0.19 -0.13 -0.2 -0.13 - -0.15 -0.2 -0.18 - -0.19 -0.16 -0.09 - -1.19 -0.03 -0.05 - -1.37 -0.08 -0.02 - -0.04 -0.06 -0.03 - -0.09 -0.11 -0.11

ROE %

245.84 258.27 69.94 -280.52 -332.40 -330.58 -181.58 -185.16 -193.99 -150.95 -139.82 -43.87 -50.93 -49.15 -43.75 -66.70 -75.91 -78.59 -79.31 -42.75 -46.58 -49.10 -44.82 -42.28 -34.21 -25.10 -20.83 -16.06 -13.74 -13.25 -15.14 -15.01 -23.97 -30.29 -29.60 -17.99 -48.50 -70.03 -323.66 -308.04 -306.97 -275.41 -26.54 -37.38 49.69 135.69 208.59 177.79 175.80 86.75 31.85 15.98 -1.99 7.18 10.79

ROA %

-79.68 -72.49 -109.12 -66.08 -82.68 -81.37 -59.43 -65.72 -71.63 -60.95 -63.43 -28.87 -33.66 -32.52 -29.49 -45.24 -52.60 -55.59 -57.69 -34.15 -36.82 -38.45 -34.76 -32.50 -27.20 -20.77 -18.38 -15.28 -12.92 -12.29 -13.70 -13.39 -20.98 -26.20 -25.30 -15.22 -24.08 -25.35 -95.64 -89.46 -115.08 -131.83 204.61 901.14 41.78 -791.97 -1665.70 -1754.86 -1745.61 -877.00 -297.68 -74.32 9.25 -33.39 -50.17

ROCE %

52.01 34.11 -54.44 -228.60 -304.24 -328.45 -272.62 -229.95 -248.60 -191.61 -150.82 -50.42 -56.52 -43.96 -39.82 -65.27 -74.47 -78.27 -79.54 -43.20 -47.44 -50.17 -46.10 -43.39 -35.10 -25.63 -21.23 -16.36 -16.44 -18.51 -20.32 -18.21 -27.32 -31.20 -30.51 -18.15 -31.30 -35.34 -43.84 -55.32 -50.61 -32.75 -5.16 21.11 26.71 27.60 23.10 18.14 28.27 32.80 37.10 35.14 10.13 12.80 12.21

Current Ratio

1.6 2.2 0.9 1.3 1.5 1.2 1.5 1.7 1.7 1.8 2.3 2.8 3.0 2.8 3.0 3.1 3.1 3.1 3.1 5.0 5.0 5.0 5.0 4.3 4.3 4.3 4.3 20.6 20.6 20.6 20.6 9.3 9.3 9.3 9.3 6.5 6.5 6.5 6.5 1.4 1.4 1.4 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2 0.2 0.2 0.2

DSO

- - - - - - - - 69.4 45.6 395.6 - - - - - 45.6 - - - - - - - 4.3 26.8 3.3 - 44.6 45.0 56.7 - 61.5 52.9 46.4 - 36.8 37.2 26.5 - 13.5 12.9 23.9 - 35.7 14.5 34.1 - 88.0 111.1 29.1 - 29.2 202.6 -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

- - - - - - - - 69.4 45.6 395.6 - - - - - 45.6 - - - - - - - 4.3 26.8 3.3 - 44.6 45.0 56.7 - 61.5 52.9 46.4 - 36.8 37.2 26.5 - 13.5 12.9 23.9 - 35.7 14.5 34.1 - 88.0 111.1 29.1 - 29.2 202.6 -

Finanzkreislauf

- - - - - - - - 69.4 45.6 395.6 - - - - - 45.6 - - - - - - - 4.3 26.8 3.3 - 44.6 45.0 56.7 - 61.5 52.9 46.4 - 36.8 37.2 26.5 - 13.5 12.9 23.9 - 35.7 14.5 34.1 - 88.0 111.1 29.1 - 29.2 202.6 -

Alle Zahlen in USD-Währung